Back to Authors

Grosch, Heidrun

A5019165095 | I223822909

Mayo Clinic

Heidelberg University

Citations 2

Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma

Acta Oncologica | September 28, 2018 | Volume: 57 | Issue: 12 | Pages: 1713-1720

10.1080/0284186x.2018.1502467 | PMID 30264630

A randomized, open-label, phase 2 study of emibetuzumab plus erlotinib (LY+E) and emibetuzumab monotherapy (LY) in patients with acquired resistance to erlotinib and MET diagnostic positive (MET Dx+) metastatic NSCLC.

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 9070-9070

10.1200/jco.2016.34.15_suppl.9070